A new report for the treatment of serious cases of the new Novel Corona virus disease Cod-19 is expected to make positive progress.
Experts have long been urging the decades-old way of treating more sick people than the blood of those who have recovered from the disease.
Now a new research has revealed the preliminary results of this procedure, which is very encouraging.
The study, published Friday in the Medical Journal of the American Medical Association, revealed the use of this procedure on nearby patients in a Chinese hospital.
These Cod19 patients underwent experimental blood plasma transfusion and significantly improved their condition.
Although this research was limited and on a very small scale and difficult to conclude, the results reinforce the idea of the usefulness of this method.
New York State, the most affected by the disease in the United States, was announced this week to test plasma transfusion for serious cases.
Doctors used bloodplasma on 5 patients aged 36 to 73 years, from January 20 to March 25, at the Shenzhen Hospital, China.
The plasma was given to these patients within 10 to 22 days of admission to the hospital.
Within 3 days after plasma transfusion, 4 out of 5 patients have normal body temperature, 4 out of 5 patients have severe respiratory problems within 12 days.
According to the research published on Friday, 3 patients were discharged from the hospital while 2 were in stable condition, but were currently in need of a ventilator.
Other medical experts on the study said it was limited, while these patients were also being used on experimental antiviral drugs and steroids, making it difficult to say conclusively about the efficacy of plasma transfusion.
But Chinese scientists involved in the study say the findings highlight the possibility of using antibodies for healthy people for plasma therapy, which could improve their condition by getting rid of more sick people with the virus.
This type of procedure was also used during the 2002 SARS virus outbreak and the 2009 swine flu outbreak.
In this new study, this experimental procedure was tested by receiving blood donations from the health reminders of Cod19 and receiving blood plasma from them and transferred to critically ill patients on the same day.
If this procedure is effective on a large hematoma, the major challenge will be to obtain blood donations from healthy individuals.
Just this week, research from the Washington University School of Medicine in the United States also said that the blood of cured 19 patients could prevent the treatment of critically ill patients, as well as others.
This method was used during the Spanish flu outbreak of 1918, before vaccine or antiviral drugs were available.
This procedure is based on the fact that healthy patients have powerful antibodies in their blood that are trained to fight the virus.
Be aware that there is currently no cure for the new nasal corona virus, while the availability of the vaccine may not be possible until the end of this year or the first half of next year.
According to Dr. Jeffrey Henderson, Associate Professor at the University of Washington, the use of serum obtained from the blood of recently recovered patients may seem old-fashioned, but historically it has been useful.
“By using it we have been able to prevent and treat virus infections such as measles, polio and influenza, but once the vaccine is developed, this technique is forgotten,” he added.
“As long as Cod 19 produces specific drugs and vaccines, this method will help save lives,” he said.
Doctors did not have any treatment during the Spanish flu outbreak, so they helped many people recover by using blood serum to recover patients.
Blood plasma and serum are made of transparent blood fluid and both are equipped with antibodies, but plasma contains some other helpful proteins that are not in serum.
Prior to Washington University, Johns Hopkins University and Mayo Clinic also started trials on this method with regard to Code 19.
His recommendations were submitted March 18 to the Food and Drug Administration of the United States and he is awaiting permission to try them on humans.
Dr. Jeffrey Anderson said that this is a step that needs to be taken urgently; it is faster than drug preparation because it will require plasma donation and transplantation.
He said, “As soon as a person is cured, he will be a potential donor to us, and we can use the Bloodbank system to obtain plasma and distribute it to patients in need.” If this method works, it will provide a lifeline in the early stages of this outbreak. ‘
The research team is now about to request a blood donation from healthy patients, from which the haloesma will be isolated and transplanted into the sick after screening for toxic materials and viruses.